TIVDAK® What is TIVDAK?

(tisotumab vedotin-tftv)

What is TIVDAK?

TIVDAK is a prescription medicine used to treat adults with cervical cancer:

that has returned or has spread to other parts of the body, and
who have received chemotherapy that did not work or is no longer working.

It is not known if TIVDAK is safe and effective in children.

Before receiving TIVDAK, tell your healthcare provider about all of your medical conditions, including if you:

have a history of vision or eye problems
have numbness or tingling in your hands or feet
have bleeding problems
have liver problems
are pregnant or plan to become pregnant. TIVDAK can harm your unborn baby. Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with TIVDAK.
Females who are able to become pregnant:
- Your healthcare provider should do a pregnancy test before you start treatment with TIVDAK.
- You should use an effective birth control during treatment and for 2 months after your last dose of TIVDAK.
Males with female partners who are able to become pregnant:
- You should use an effective birth control during treatment and for 4 months after your last dose of TIVDAK.
are breastfeeding or plan to breastfeed. It is not known if TIVDAK passes into your breast milk. Do not breastfeed during treatment and for 3 weeks after your last dose of TIVDAK.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Taking TIVDAK with certain other medicines may cause side effects.

Find TIVDAK® medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

TIVDAK® Quick Finder

Medication Guide

Health Professional Information

What is TIVDAK?

TIVDAK is a prescription medicine used to treat adults with cervical cancer:

that has returned or has spread to other parts of the body, and
who have received chemotherapy that did not work or is no longer working.

It is not known if TIVDAK is safe and effective in children.

Before receiving TIVDAK, tell your healthcare provider about all of your medical conditions, including if you:

have a history of vision or eye problems
have numbness or tingling in your hands or feet
have bleeding problems
have liver problems
are pregnant or plan to become pregnant. TIVDAK can harm your unborn baby. Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with TIVDAK.
Females who are able to become pregnant:
- Your healthcare provider should do a pregnancy test before you start treatment with TIVDAK.
- You should use an effective birth control during treatment and for 2 months after your last dose of TIVDAK.
Males with female partners who are able to become pregnant:
- You should use an effective birth control during treatment and for 4 months after your last dose of TIVDAK.
are breastfeeding or plan to breastfeed. It is not known if TIVDAK passes into your breast milk. Do not breastfeed during treatment and for 3 weeks after your last dose of TIVDAK.

Prescribing Information

Download Prescribing Information

Health Professional Information

What is TIVDAK?

TIVDAK is a prescription medicine used to treat adults with cervical cancer:

that has returned or has spread to other parts of the body, and
who have received chemotherapy that did not work or is no longer working.

It is not known if TIVDAK is safe and effective in children.

Before receiving TIVDAK, tell your healthcare provider about all of your medical conditions, including if you:

have a history of vision or eye problems
have numbness or tingling in your hands or feet
have bleeding problems
have liver problems
are pregnant or plan to become pregnant. TIVDAK can harm your unborn baby. Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with TIVDAK.
Females who are able to become pregnant:
- Your healthcare provider should do a pregnancy test before you start treatment with TIVDAK.
- You should use an effective birth control during treatment and for 2 months after your last dose of TIVDAK.
Males with female partners who are able to become pregnant:
- You should use an effective birth control during treatment and for 4 months after your last dose of TIVDAK.
are breastfeeding or plan to breastfeed. It is not known if TIVDAK passes into your breast milk. Do not breastfeed during treatment and for 3 weeks after your last dose of TIVDAK.

Resources

Didn’t find what you were looking for? Contact us.

MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985^*

*Contact Medical Information.9AM-5PM ET Monday to Friday; excluding holidays.

Report Adverse Event

Pfizer Safety

To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.